Company: FENC
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001558370-25-003710
Chunk: 16

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 9B
Chunk 16
---
Item 9B.      Other Information

Insider Adoption or Termination of Trading ArrangementsRostislav Raykov, a current member of our Board of Directors, adopted a trading arrangement on September 23, 2024, which is intended to satisfy the Rule 10b5-1 affirmative defense. This trading arrangement covers the disposition of up to 120,000 shares of the Company’s common shares, and will terminate on December 31, 2025, unless earlier terminated in accordance with its terms. No additional directors or officers informed us of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.

​